Samuel Mireles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel Mireles has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin A. Pinsky
Department of Pathology, Stanford University School of Medicine, Stanford, USA
1 shared publication Birgit Maass
Department of Anesthesiology Perioperative and Pain Medicine, Stanford University School of Medicine Stanford California USA
1 shared publication- Christine G. Jette
Department of Anesthesiology Perioperative and Pain Medicine, Stanford University School of Medicine Stanford California USA
1 shared publication - Ellen Y. Wang
Stanford Chariot Program, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, USA
1 shared publication - Genevieve D'SOuza
Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA
1 shared publication - Janice Y. Man
Department of Anesthesiology Perioperative and Pain Medicine, Stanford University School of Medicine Stanford California USA
1 shared publication
Latest Publications
- 5 April 2022
- Published by Wiley in Pediatric Anesthesia
- Vol. 32 (6) , 692-696
Novel utilization of strand‐specific reverse transcription polymerase chain reaction in perioperative clinical decision making for SARS‐CoV‐2 polymerase chain reaction positive patients
In order to prevent in-hospital transmission and potential complications related to SARS-CoV-2 in the perioperative patient, most healthcare institutions require preoperative testing for SARS-CoV-2 prior to proceeding with elective surgery. The Centers for Disease Control and Prevention (CDC) recommends a time and symptom-based duration of isolation for the presumed infectious period. The guidance to avoid retesting of asymptomatic patients in the 90 days following a positive reverse transcription polymerase chain reaction (RT-PCR) test is because of the possibility of detection of non-infectious viral shedding. When to reschedule asymptomatic patients who test RT-PCR positive for SARS-CoV-2 preoperatively is of considerable debate, both from the perspective of ensuring a patient's full preoperative fitness, as well as reducing the risk of viral transmission within the hospital. We describe the novel perioperative use of a strand-specific assay to detect minus strand ribonucleic acid (RNA) in a clinical decision-making algorithm to determine optimal timing of elective surgery after a patient tests RT-PCR positive for SARS-CoV-2. This is the first description in the literature of an attempt to further stratify patients who repeatedly test positive for SARS-CoV-2 into infectious versus non-infectious for perioperative planning.
- 5 April 2022
- Published by Wiley in Pediatric Anesthesia
- Vol. 32 (6) , 692-696
Novel utilization of strand‐specific reverse transcription polymerase chain reaction in perioperative clinical decision making for SARS‐CoV‐2 polymerase chain reaction positive patients
In order to prevent in-hospital transmission and potential complications related to SARS-CoV-2 in the perioperative patient, most healthcare institutions require preoperative testing for SARS-CoV-2 prior to proceeding with elective surgery. The Centers for Disease Control and Prevention (CDC) recommends a time and symptom-based duration of isolation for the presumed infectious period. The guidance to avoid retesting of asymptomatic patients in the 90 days following a positive reverse transcription polymerase chain reaction (RT-PCR) test is because of the possibility of detection of non-infectious viral shedding. When to reschedule asymptomatic patients who test RT-PCR positive for SARS-CoV-2 preoperatively is of considerable debate, both from the perspective of ensuring a patient's full preoperative fitness, as well as reducing the risk of viral transmission within the hospital. We describe the novel perioperative use of a strand-specific assay to detect minus strand ribonucleic acid (RNA) in a clinical decision-making algorithm to determine optimal timing of elective surgery after a patient tests RT-PCR positive for SARS-CoV-2. This is the first description in the literature of an attempt to further stratify patients who repeatedly test positive for SARS-CoV-2 into infectious versus non-infectious for perioperative planning.